Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications
Biswajit Naik, Venkata Satish Kumar Mattaparthi, Nidhi Gupta, Rupal Ojha, Pundarikaksha Das, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
Abstract
, and clinical studies will guide these drugs' proper allocation to treat COVID-19.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
DrugMedicineDrug repositioningPharmacologyDrug developmentDiseaseRepurposingDrug resistancePandemicApproved drugClinical trialEfficacyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Drug discoveryIntensive care medicineBioinformaticsBiologyInternal medicineMicrobiologyEcologySARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies